Survivin Antikörper
-
- Target Alle Survivin (BIRC5) Antikörper anzeigen
- Survivin (BIRC5) (Baculoviral IAP Repeat-Containing 5 (BIRC5))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser Survivin Antikörper ist unkonjugiert
-
Applikation
- ELISA, Luminex Assay (LMNX)
- Immunogen
- Full length human recombinant protein of human BIRC5 (NP_001159) produced in HEK293T cell.
- Klon
- OTI2D9
- Isotyp
- IgG1
- Top Product
- Discover our top product BIRC5 Primärantikörper
-
anti-Baculoviral IAP Repeat-Containing 5 (BIRC5) (AA 85-142) antibody
BIRC5 Reaktivität: Human, Maus WB, ELISA, IHC (p), FACS, IF (cc), IF (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Baculoviral IAP Repeat-Containing 5 (BIRC5) (AA 1-100) antibodyBIRC5 Reaktivität: Human WB, ELISA, IF, IP, RNAi Wirt: Maus Monoclonal 5B10 unconjugated
anti-Baculoviral IAP Repeat-Containing 5 (BIRC5) (AA 1-142) antibodyBIRC5 Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Baculoviral IAP Repeat-Containing 5 (BIRC5) (AA 1-142) antibodyBIRC5 Reaktivität: Human WB, IHC, ICC, IP Wirt: Maus Monoclonal 1# unconjugated
anti-Baculoviral IAP Repeat-Containing 5 (BIRC5) antibodyBIRC5 Reaktivität: Human WB, ELISA, IHC, ICC, FACS Wirt: Maus Monoclonal 1H5 unconjugated
anti-Baculoviral IAP Repeat-Containing 5 (BIRC5) (pThr117) antibodyBIRC5 Reaktivität: Human, Maus, Ratte WB, ELISA, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Baculoviral IAP Repeat-Containing 5 (BIRC5) (C-Term) antibodyBIRC5 Reaktivität: Human WB, IF, IHC (p), ICC, IP Wirt: Kaninchen Polyclonal unconjugated
anti-Baculoviral IAP Repeat-Containing 5 (BIRC5) (AA 1-142) antibodyBIRC5 Reaktivität: Human WB, IF, IP Wirt: Kaninchen Polyclonal unconjugated
anti-Baculoviral IAP Repeat-Containing 5 (BIRC5) (AA 1-142) antibodyBIRC5 Reaktivität: Human WB, IF, PLA Wirt: Kaninchen Polyclonal unconjugated
anti-Baculoviral IAP Repeat-Containing 5 (BIRC5) (AA 1-142) antibodyBIRC5 Reaktivität: Human WB, IHC, ICC, IP Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- ELISA, LMNX 1:100 - 1:1000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 0.5 mg/mL
-
- Target
- Survivin (BIRC5) (Baculoviral IAP Repeat-Containing 5 (BIRC5))
- Andere Bezeichnung
- BIRC5 (BIRC5 Produkte)
- Synonyme
- AP14 antikoerper, API4 antikoerper, EPR-1 antikoerper, AAC-11 antikoerper, Api4 antikoerper, TIAP antikoerper, survivin40 antikoerper, bir5a antikoerper, survivin antikoerper, BIR1 antikoerper, Su2 antikoerper, XBIR1 antikoerper, XSurvivin1 antikoerper, Xsvv1 antikoerper, api4 antikoerper, bir1-A antikoerper, epr-1 antikoerper, svv1 antikoerper, xSurvivin antikoerper, xsurv antikoerper, Su1 antikoerper, birc5.2 antikoerper, svv2 antikoerper, xSurvivin2 antikoerper, bir5b antikoerper, SIX antikoerper, birc5.2-a antikoerper, birc5.2-b antikoerper, baculoviral IAP repeat containing 5 antikoerper, baculoviral IAP repeat-containing 5 antikoerper, baculoviral IAP repeat containing 5a antikoerper, baculoviral IAP repeat-containing 5, gene 1 L homeolog antikoerper, baculoviral IAP repeat containing 5 L homeolog antikoerper, baculoviral IAP repeat containing 5b antikoerper, baculoviral IAP repeat containing 5 S homeolog antikoerper, BIRC5 antikoerper, Birc5 antikoerper, birc5a antikoerper, birc5.1.L antikoerper, birc5.2.L antikoerper, birc5b antikoerper, birc5.2.S antikoerper
- NCBI Accession
- NM_001168
- HGNC
- 332
- Pathways
- Apoptose, Zellzyklus, Nuclear Hormone Receptor Binding
-
